Incidence and prevalence of idiopathic pulmonary fibrosis
- PMID: 16809633
- DOI: 10.1164/rccm.200602-163OC
Incidence and prevalence of idiopathic pulmonary fibrosis
Abstract
Rationale: Idiopathic pulmonary fibrosis is a chronic interstitial lung disease of unknown etiology; its epidemiology in the United States has not been well characterized.
Objective: To estimate the annual incidence and prevalence of idiopathic pulmonary fibrosis in the United States.
Methods: Retrospective cohort design utilizing a large health care claims database spanning the period January 1996 through December 2000.
Measurements and main results: Persons with idiopathic pulmonary fibrosis were identified based on diagnosis and procedure codes. Using broad case-finding criteria, prevalence was estimated to range from 4.0 per 100,000 persons aged 18 to 34 yr to 227.2 per 100,000 among those 75 yr or older; annual incidence was estimated to range from 1.2 to 76.4 per 100,000. Using narrow case-finding criteria, prevalence ranged from 0.8 to 64.7 per 100,000 persons; comparable figures for incidence were 0.4 to 27.1 per 100,000 persons. Extrapolating these rates to the overall United States' population, prevalence was estimated to be 42.7 per 100,000 (incidence, 16.3 per 100,000) using broad criteria; with narrow criteria, prevalence was estimated to be 14.0 per 100,000 (incidence, 6.8 per 100,000).
Conclusions: Our results suggest that idiopathic pulmonary fibrosis is probably more common in the United States than previously reported.
Similar articles
-
Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan.Muscle Nerve. 2012 May;45(5):676-83. doi: 10.1002/mus.23302. Muscle Nerve. 2012. PMID: 22499094
-
Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11.Lancet Respir Med. 2014 Jul;2(7):566-72. doi: 10.1016/S2213-2600(14)70101-8. Epub 2014 May 27. Lancet Respir Med. 2014. PMID: 24875841
-
Idiopathic Pulmonary Fibrosis in United States Automated Claims. Incidence, Prevalence, and Algorithm Validation.Am J Respir Crit Care Med. 2015 Nov 15;192(10):1200-7. doi: 10.1164/rccm.201504-0818OC. Am J Respir Crit Care Med. 2015. PMID: 26241562
-
Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature.Eur Respir Rev. 2012 Dec 1;21(126):355-61. doi: 10.1183/09059180.00002512. Eur Respir Rev. 2012. PMID: 23204124 Free PMC article. Review.
-
Does idiopathic pulmonary fibrosis increase lung cancer risk?Am J Respir Crit Care Med. 2000 Jan;161(1):1-2. doi: 10.1164/ajrccm.161.1.ed14-99. Am J Respir Crit Care Med. 2000. PMID: 10619788 Review. No abstract available.
Cited by
-
Prognostic model of fibroblasts in idiopathic pulmonary fibrosis by combined bulk and single-cell RNA-sequencing.Heliyon. 2024 Jul 11;10(14):e34519. doi: 10.1016/j.heliyon.2024.e34519. eCollection 2024 Jul 30. Heliyon. 2024. PMID: 39113997 Free PMC article.
-
A Newfoundland cohort of familial and sporadic idiopathic pulmonary fibrosis patients: clinical and genetic features.Respir Res. 2012 Aug 1;13(1):64. doi: 10.1186/1465-9921-13-64. Respir Res. 2012. PMID: 22853774 Free PMC article.
-
PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis.J Clin Invest. 2015 Feb;125(2):521-38. doi: 10.1172/JCI74942. Epub 2014 Dec 22. J Clin Invest. 2015. PMID: 25562319 Free PMC article.
-
The derepression of transposable elements in lung cells is associated with the inflammatory response and gene activation in idiopathic pulmonary fibrosis.Mob DNA. 2021 Jun 9;12(1):14. doi: 10.1186/s13100-021-00241-3. Mob DNA. 2021. PMID: 34108012 Free PMC article.
-
Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials.Am J Respir Crit Care Med. 2012 May 15;185(10):1044-8. doi: 10.1164/rccm.201201-0006PP. Epub 2012 Apr 13. Am J Respir Crit Care Med. 2012. PMID: 22505745 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical